Publication | Closed Access
CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis
46
Citations
22
References
2022
Year
EngineeringIn Vivo Gene TherapyImmunologyMolecular BiologyCell DeathPharmacotherapyDisease PhysiologyInflammationTranslational MedicineTranslational BiologyDisease PathophysiologyClinical TrialsCrisprEpub 2021Vivo GeneAug 5Vascular BiologyPharmacologyCell BiologyMolecular MedicineDisease MechanismJun 26Genetic EngineeringExperimental TherapeuticTranslational ResearchGene EditingMedicineGenome Editing
N Engl J Med. 2021 Aug 5;385(6):493–502. PMID: 34215024 doi: 10.1056/NEJMoa2107454. Epub 2021 Jun 26.
| Year | Citations | |
|---|---|---|
Page 1
Page 1